SCHEMBL9054273

SCHEMBL9054273

CC(C)(O)CCCCn1c(=O)c2c(ncn2Cc2ccccc2)n(Cc2ccccc2)c1=O

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
POLB P06746 1/20 0.57
HIF1A Q16665 1/20 0.57
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
ADORA2B P29275 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
CNOT7 Q9UIV1 6/20 0.53
PDE1A P54750 1/20 0.53
PDE1B Q01064 1/20 0.53
PDE1C Q14123 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7561563 0.94 POLB (0.55) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL10346505 0.92 POLB (0.69) ALDH1A1SMN1; SMN2POLBHIF1ATSHR
SCHEMBL7559639 0.91 POLB (0.68) ALDH1A1SMN1; SMN2POLBHIF1ATSHR
SCHEMBL7561501 0.91 POLB (0.56) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL9054420 0.90 KMT2A (0.52) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL7562065 0.88 POLB (0.71) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL7563973 0.86 POLB (0.58) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL7560381 0.86 POLB (0.53) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL7559268 0.84 POLB (0.73) ALDH1A1SMN1; SMN2POLBHIF1AKMT2A
SCHEMBL7563991 0.83 POLB (0.66) ALDH1A1SMN1; SMN2POLBHIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0528164-B1 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata HOECHST AG (DE) 1996-05-29 EP disclosed
US-5409935-A Inhibit formation of free radicals HOECHST AKTIENGESELLSCHAFT (DE) 1995-04-25 US disclosed
EP-0528164-A2 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata HOECHST AKTIENGESELLSCHAFT (DE) 1993-02-24 EP disclosed